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Abstract
Background: Fetal conditions can in principle be affected by the mother’s genotype working through the prenatal
environment.
Methodology/Principal Findings: Genotypes for 1536 SNPs in 357 cleft candidate genes were available from a previous
analysis in which we focused on fetal gene effects [1]. After data-cleaning, genotypes for 1315 SNPs in 334 autosomal genes
were available for the current analysis of maternal gene effects. Two complementary statistical methods, TRIMM and
HAPLIN, were used to detect multi-marker effects in population-based samples from Norway (562 case-parent and 592
control-parent triads) and Denmark (235 case-parent triads). We analyzed isolated cleft lip with or without cleft palate (iCL/
P) and isolated cleft palate only (iCP) separately and assessed replication by looking for genes detected in both populations
by both methods. In iCL/P, neither TRIMM nor HAPLIN detected more genes than expected by chance alone; furthermore,
the selected genes were not replicated across the two methods. In iCP, however, FLNB was identified by both methods in
both populations. Although HIC1 and ZNF189 did not fully satisfy our stringency criterion for replication, they were strongly
associated with iCP in TRIMM analyses of the Norwegian triads.
Conclusion/Significance: Except for FLNB, HIC1 and ZNF189, maternal genes did not appear to influence the risk of clefting
in our data. This is consistent with recent epidemiological findings showing no apparent difference between mother-to-
offspring and father-to-offspring recurrence of clefts in these two populations. It is likely that fetal genes make the major
genetic contribution to clefting risk in these populations, but we cannot rule out the possibility that maternal genes can
affect risk through interactions with specific teratogens or fetal genes.
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Introduction
With an average worldwide prevalence of 1/800 live births,
orofacial clefts are among the most common human birth defects
[2]. Even with corrective surgery, patients face a lifetime of
functional, social, and aesthetic challenges. Clefting has also been
linked to an elevated risk of cancer in later life [3], and an
increased overall mortality well into adulthood [4]. Despite
significant progress in the identification of genetic and environ-
mental risk factors for clefting [5,6], the vast majority of isolated
cleft cases still have no known cause.
Fetal conditions may be caused by the fetal genotype, and also
by the mother’s genotype working through the prenatal environ-
ment. Under assumed genetic mating symmetry, contributions
through the maternal genotype would be apparent as over-
representation of risk alleles in the maternal compared to the
paternal genotype, among parents of affected offspring. Such
maternally-mediated effects could confound a case-control study of
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fetal effects, due to correlation between the baby’s and mother’s
genotype. To help disentangle offspring-mediated gene effects
from those that are maternally-mediated, powerful analytic tools
have been devised based on offspring-parent triads. Such methods
test for the asymmetric distribution of a particular risk allele/
haplotype between mothers and fathers (to detect maternally-
mediated effects), and between affected offspring and their biologic
parents (to detect offspring-mediated effects) [7,8,9]. We used two
such methods, TRIMM [10] and HAPLIN [7], applied to two
large population-based samples from Scandinavia (Norway and
Denmark), and using one of the largest available collections of cleft
candidate genes, in order to investigate whether maternal genes
influence the fetal risk of iCL/P and iCP.
Materials and Methods
Participants
A population-based case-control study of orofacial clefts in
Norway (1996–2001) provided 562 case-parent triads and 592
control-parent triads for analysis. Of the 562 case-parent triads,
311 were iCL/P and 114 were iCP. An additional 183 iCL/P and
69 iCP case-parent triads were available from a population-based
study of orofacial clefts in Denmark (1991–2001). Details
regarding study design and characteristics of study participants
have been provided elsewhere [11,12].
Data analysis
Genotypes for 1536 SNPs in 357 cleft candidate genes were
available from a previous analysis in which we searched for fetal
gene effects in the same dataset [1]. After data-cleaning and
exclusion of SNPs on the X-chromosome, genotypes for 1315
SNPs in 334 autosomal genes were available for the current
analysis of maternal gene effects. We categorized these genes
according to functional group and biological pathway to enable a
biologically more meaningful interpretation of the results (for a
complete list of these genes and pathways, see Table S1). Two
statistical software packages, TRIMM [10] and HAPLIN [7], were
used to scan for associations in the Norwegian and Danish
samples. Both methods were designed to detect fetal or maternal
gene effects separately using case-parent triads, although in
different ways [1]. To assess a potential maternally-mediated gene
effect, TRIMM constructs a difference vector by taking the
genotype differences between the mother and the father. Under
the genetic mating symmetry assumption [13], the difference
vector has an expected value of 0 at each locus under the null
hypothesis. TRIMM is nonparametric and generates a combined
p-value by integrating results from two complementary tests: max-
Z and Hotelling’s T2. HAPLIN is a haplotype-based extension of
the log-linear modeling approach [9] and uses maximum
likelihood to estimate and test for maternal gene effects under
the same genetic mating symmetry assumption. The missing phase
information is accommodated by use of the Expectation-
Maximization algorithm [7]. It is worth noting that effects of
maternal genes are not confounded by effects of fetal genes in
either of the methods.
TRIMM is nonparametric and can accommodate population
structure, deviation from Hardy-Weinberg equilibrium, multiple
SNPs, missing SNPs, and non-negligible recombination rates. When
applied to a set of SNPs within a gene, TRIMM accounts for within-
gene SNP correlations by permuting alleles at all SNPs simulta-
neously. In contrast, HAPLIN is parametric and estimates the full
haplotype distribution over a set of SNPs and also provides estimates
of relative risk for each haplotype. HAPLIN produces a complete
description of the ‘risk structure’ over the set of haplotypes in a region
through the use of a full maximum likelihood model. Compared with
TRIMM, HAPLIN requires Hardy-Weinberg equilibrium and
assumes no recombination. In the current analyses, we used three
SNPs in a sliding-window haplotype analysis of the iCL/P and iCP
case-parent triads. Longer window-lengths may generate many rare
(and perhaps irrelevant) haplotypes, particularly when the sample size
is limited. Details on the sliding-window approach and adjustment of
the resulting p-values for within-gene multiple testing have been
provided in [1].
HAPLIN handles incomplete triads by implementing a
maximum likelihood model and by using the expectation
maximization (EM) algorithm to impute missing triads. The
estimated p-values and confidence intervals are subsequently
adjusted to account for the imputation procedure itself. To ensure
that maternal gene effects will not be confounded with fetal gene
effects, TRIMM uses only complete triads. For randomly missing
genotypes, TRIMM replaces the corresponding difference vector
with zero—the expected value under the null.
We opted not to combine the Norwegian and Danish samples
(although this would have boosted statistical power) because we had
no prior reason to believe that the same genetic variants or
haplotypes contribute to the risk of isolated clefts in both
populations. In fact, our recent analysis of fetal gene effects in the
same two study populations showed evidence of across-population
differences [1]. Thus, TRIMM and HAPLIN analyses were
performed separately on the Norwegian and Danish iCL/P and
iCP triads (a total of four sets of analyses). We assessed the
distribution of the resulting p-values from these analyses using a
Schweder-Spjøtvoll plot [14], which is a simple graphical procedure
for the simultaneous evaluations of many tests. In the absence of
association, the observed p-values are expected to fall along the
sloping line representing the uniform distribution under the null.
For genes that are truly associated with disease, the corresponding
p-values are expected to deviate from this sloping line.
As an alternative to correcting for multiple-testing using a full
Bonferroni correction, we used quantile-quantile (QQ) plots to
visually inspect whether our analyses produced more significant
results than would have been expected by chance alone. QQ plots
were generated for each cleft type (iCL/P and iCP) after p-values
from the Norwegian and Danish analyses were combined using
Fisher’s method [15]. If the distribution of p-values is identical to
the null distribution (for no association), points in the QQ plot are
expected to follow the uniform diagonal line. Conversely, large-
effect susceptibility loci are expected to deviate from the uniform
distribution at the highly significant end of the distribution.
Finally, to verify whether the genetic mating symmetry
assumption [13] holds in our data, we compared the QQ plots
for the maternal gene effect analyses on the Norwegian control-
parent triads with those on the case-parent triads. The rationale is
that if the control results show departures from uniformity that are
as inflated as those for the case-parent triad analyses, then there
may be some violations of mating symmetry in the population.
Software
TRIMM and HAPLIN are available for the R computing
environment [16] from our web sites (TRIMM: http://www.
niehs.nih.gov/research/atniehs/labs/bb/staff/weinberg/index.cfm
#downloads; HAPLIN: http://www.uib.no/smis/gjessing/genetics/
software/haplin).
Ethics approval
The Norwegian Data Inspectorate, the Regional Committee on
Research Ethics for Western Norway, and the respective
Institutional Review Boards of the US National Institute of
Maternal Genes and Clefts
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Environmental Health Sciences (NIH/NIEHS) and the University
of Iowa approved the study. Ethics approval for the Danish
orofacial clefts study was obtained from the Danish National
Committee on Biomedical Research Ethics. Clinicopathological
information and biologic specimens for DNA extraction were
obtained from all participating families with the informed consent
of the mothers and fathers, and all aspects of this research were in
compliance with the tenets of the Declaration of Helsinki for human
research (http://www.wma.net).
Results
Figures 1 and 2 represent Schweder-Spjøtvoll plots for all
genes with p-values #0.1 from TRIMM and HAPLIN analyses of
the Norwegian and Danish iCL/P and iCP samples, respectively.
More detailed summaries of these results by analytic method, cleft
type, and population are presented in Tables S2, S3, S4, and
S5, as are Fisher-combined p-values for iCL/P and iCP after
separate TRIMM and HAPLIN analyses in each population.
To evaluate replication, we looked at genes that achieved a p-
value #0.1 in both Norway and Denmark. If the 334 genes were
all unlinked, one would expect about 3 genes (0.160.16334 genes)
to ‘replicate’ by chance alone. For TRIMM and HAPLIN analyses
of iCL/P, there were exactly 3 genes that replicated in this manner
(Figures 1A and 2A; pairs of identical genes are linked by lines
joining the two plots). For iCP, there were 8 genes shared in the
two samples in the TRIMM analysis, and 7 shared genes in the
HAPLIN analysis (Figures 1B and 2B). While this is more than
the 3 expected by chance, there was only one gene, FLNB (filamin
B, beta), that was replicated by both methods across both
populations.
The genes for hypermethylated in cancer 1 (HIC1) and zinc
finger protein 189 (ZNF189) did not fully meet our stringency
criterion for replication (both methods detecting associations in
both populations). Nevertheless, they were the top two genes
associated with iCP in TRIMM analyses of the Norwegian triads
(upper panel, Figure 1B). Only TRIMM found an association
with HIC1 in both populations (Figure 1B), while only HAPLIN
Figure 1. TRIMM analyses of the Norwegian and Danish samples. Schweder-Spjøtvoll plot of p-values for (A) isolated cleft lip with or without
cleft palate (iCL/P) and (B) isolated cleft palate (iCP). All genes with p-values #0.1 are shown on the X-axis and ordered according to observed p-
values (Y-axis). Genes with p-values #0.05 are highlighted in red. The sloping line represents the expected uniform distribution under the null (of no
association). Genes with p-values #0.1 in both the Norwegian and Danish samples are indicated by lines connecting the upper (Norway) and lower
(Denmark) plots.
doi:10.1371/journal.pone.0011493.g001
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detected an association with ZNF189 in both populations
(Figure 2B).
When the distribution of the observed Fisher-combined p-values
was contrasted with that of the null, HIC1 and FLNB in iCP
analyses showed marked deviations at the significant end of the
distributions in the corresponding QQ plots (Figure 3). Finally, to
assess plausibility of the genetic mating symmetry assumption, we
compared QQ plots for case-parent triads with those for the
Norwegian control-parent triads. The QQ plots for the Norwegian
control-parent triads (Figure 3) do not look different from a
typical null plot and thus support the genetic mating symmetry
assumption.
Discussion
Our search for maternally-mediated genetic risk of orofacial
clefts in offspring was motivated by evidence from animal studies
demonstrating an ability of the products of maternal genes to
directly intervene and protect the fetus. For example, Letterio
et al. [17] showed that maternal Tgfb1 was able to cross the
placenta and rescue Tgfb12/2 mice. Similar observations were
made in an earlier experiment that tested whether maternal
epidermal growth factor (Egf) could be transported to the fetus via
the placenta [18]. In humans, however, evidence for maternal
gene effects on the risk of clefting is less direct, and the few
published studies are primarily single-gene association analyses
that provide only a partial assessment of risk. To address this
limitation, we focused here on broader gene categories and
pathways, including the cholesterol pathway, the folate/homocys-
teine pathway, and genes involved in the detoxification of
xenobiotic compounds.
Of the large number of candidate genes tested in this study, only
FLNB was detected by both methods and across both populations
in the iCP cleft category. This gene belongs to a family of actin-
binding proteins that are highly conserved and widely expressed
during development [19]. Filamins were discovered as the first
family of non-muscle actin-binding proteins [20]. They stabilize
the cytoskeletal network by cross-linking actin, and thus linking the
cell membrane to the cytoskeleton, and by providing scaffolds on
which intracellular signaling and protein trafficking pathways are
Figure 2. HAPLIN analyses of the Norwegian and Danish samples. Schweder-Spjøtvoll plot of p-values for (A) isolated cleft lip with or
without cleft palate (iCL/P) and (B) isolated cleft palate (iCP). All genes with p-values #0.1 are shown on the X-axis and ordered according to
observed p-values (Y-axis). Genes with p-values#0.05 are highlighted in red. The sloping line represents the expected uniform distribution under the
null. Genes with p-values #0.1 in both the Norwegian and Danish samples are indicated by lines connecting the upper (Norway) and lower
(Denmark) plots.
doi:10.1371/journal.pone.0011493.g002
Maternal Genes and Clefts
PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11493
Maternal Genes and Clefts
PLoS ONE | www.plosone.org 5 July 2010 | Volume 5 | Issue 7 | e11493
organized [21,22]. In humans, mutations in FLNB disrupt
vertebral segmentation, joint formation, and skeletogenesis [21].
Examples of skeletal disorders include boomerang dysplasia,
autosomal-recessive spondylocarpotarsal syndrome, autosomal-
dominant Larsen syndrome, and the perinatal lethal atelosteogen-
esis phenotypes I and III [22,23]. Interestingly, many of the
filaminopathies manifest cleft palate as part of the overall phenotype
[24,25], which is consistent with our findings of an association of
FLNB in iCP alone and not in the larger sample of iCL/P.
Unlike FLNB, HIC1 and ZNF189 did not fully meet our
stringency criterion for replication, despite being the top two genes
associated with iCP in TRIMM analyses of the Norwegian triads.
This may be due to the small size of the Danish iCP triads (69 iCP
case-parent triads), which may have limited the power to detect an
association. Nonetheless, both of these genes are plausible
candidates for orofacial clefting. HIC1 encodes a zinc-finger
transcription factor and maps to chromosome 17p13.3, within a
350 kb region found to be deleted in most patients with Miller-
Dieker lissencephaly syndrome (MDLS) [26,27,28,29]. Patients
with MDLS exhibit a range of developmental anomalies, including
omphalocele, limb and digit defects, and craniofacial dismorphol-
ogy. Further, mice lacking Hic1 die perinatally and have cleft palate
among a range of developmental defects [30,31]. The fact that
Hic12/2 mice exhibit cleft palate is noteworthy, given that the
association of HIC1 was confined to iCP in our data (with no
association seen in the larger iCL/P sample).HIC1 is also a potential
tumor suppressor gene; it is frequently hypermethylated and its
expression is downregulated in several types of cancer [29]. The link
to cancer is noteworthy given the higher risk of cancer reported
among parents whose first liveborn child had cleft lip/palate [3].
ZNF189 maps to chromosome 9q22–q31 and encodes a
Kru¨ppel-like zinc finger protein. Recent genome-wide linkage
analyses of a large number of multiplex families from diverse
populations uncovered a highly significant linkage signal to the
9q22–q33 region encompassing ZNF189 [32,33,34]. Although
several important candidate genes for clefts have been character-
ized in this region (e.g. human homolog of patched (PTCH [35]),
receptor tyrosine kinase-like orphan receptor 2 (ROR2 [36,37]),
transforming growth factor beta receptor type 1 (TGFBR1 [38]),
and forkhead box E1 (FOXE1 [33,39,40,41])), ZNF189 has not
previously been linked with clefting.
Our study was based on two national cleft cohorts of similar
ancestry, two complementary and robust statistical methods, and a
large panel of SNPs in one of the largest available collections of cleft
candidate genes. Despite the breadth of our approach, there was little
evidence to suggest that maternal genes influenced the risk of iCL/P
or iCP in our data. This apparent lack of maternal gene effects is
consistent with recent epidemiological data on familial patterns of
recurrence of orofacial clefts. If maternal genes had an impact on the
risk of clefting through effects on the uterine environment, mother-to-
offspring recurrence would be higher than father-to-offspring
recurrence. However, mother-to-offspring recurrence of clefts was
not statistically different from father-to-offspring recurrence in either
Norway or Denmark [42,43]. There was no statistically significant
difference either between parent-to-offspring and sibling-to-sibling
recurrence, suggesting that fetal genes alone are more likely to explain
the majority of genetic risk for orofacial clefts.
Our results are also consistent with those of a larger study that
investigated whether half sibships ascertained through an affected
proband had a higher risk of clefts when the mother was the
common parent [44]. A higher occurrence of clefting would be
expected if a major maternal effect exists, but no such evidence
was found in that study. Finally, in our recent pathway-wide
analysis of maternal genes and the risk of CL/P and CP among 29
genes involved in folate/one-carbon metabolism, we found no
convincing indication that genetic variants in these folate
metabolism genes play an etiologic role in orofacial clefting [45].
It is also possible that maternal genes alone do not confer risk of
clefts to the newborn unless specific environmental exposures are
also present. For example, a reduced capacity of mothers to
biotransform toxins due to a genetic susceptibility has been
proposed as a plausible explanation for the adverse effects of
smoking and alcohol consumption on pregnancy outcomes [46,47].
A non-additive interaction may be triggered only when the mothers
are exposed to smoking or alcohol during the first trimester of
pregnancy. In addition, interactions between the maternal and fetal
genotype cannot be ruled out. Such interactions should be evident
as ‘main effects’ of the participating genotypes, but the magnitude of
the apparent effect would be blunted without accounting for the
etiologic cofactor, making these effects difficult to detect.
In conclusion, with the possible exception of FLNB, HIC1 and
ZNF189, our data suggest that maternal genes do not contribute
significantly to orofacial clefting in the Norwegian and Danish
samples. This is consistent with recent reports on familial patterns
of recurrence of orofacial clefts. It is likely that fetal genes explain
the majority of genetic risk for orofacial clefts in these two
populations. However, our study does not rule out the possibility
that maternal genes may affect risk through interactions with
specific teratogens or fetal genes.
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